Organization: Health Canada
Year: 2023
Month: February
Request Number: A-2022-001006
Request Summary: Adverse Drug Reactions (ADRs) for Ondansetron. Report numbers: E2B_05672052, E2B_05635847, E2B_05627995, 001012252. ADRs for Pantoprazole sodium. Report numbers: E2B_05687063, E2B_05694473, E2B_05628332, E2B_05612082, E2B_05660986, E2B_05678047.
Disposition: Disclosed in part
Number of pages: 824